Skip to main content

Zusammenfassung

Der Schock ist definiert als eine akute, nicht oder nur kurzfristig kompensierbare Störung des Gleichgewichts zwischen O2-Angebot/-Verwertung und aktuellem O2-Bedarf auf zellulärer Ebene [23]. Er geht mit einer Fehlverteilung des Blutflusses auf der Ebene der Mikrostrombahn und damit Beeinträchtigung der für den O2- und Substrataustausch zur Verfügung stehenden Oberfläche einher. Häufigste Ursache des Schocks ist eine inadäquate kapilläre Perfusion und damit ein ungenügendes O2-Angebot auf zellulärer Ebene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams HA, Hempelmann G (1991) Therapie mit Volumenersatzmitteln. Anaesth Intensivmed 10:277–283

    Google Scholar 

  2. Adams HA, Michels R, Hempelmann G (1993) Die Indikation zum Einsatz von Humanalbumin in Anästhesie und Intensivmedizin. Anaesthesiol Intensivmed Notfallmed Schmerzther 28:66–74

    Article  CAS  Google Scholar 

  3. American College of Physicians (1992) Practice strategies for elective red blood cell transfusion. Ann Intern Med 116:403–406

    Google Scholar 

  4. American Society of Anesthesiologists (1996) Practice guidelines for blood component therapy. A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 84:732–747

    Article  Google Scholar 

  5. Arzneimittelkommission der Deutschen Ärzteschaft (2000) »UAW-News-International«: Hydroxyethylstärke (HES) — Juckreiz. Dtsch Ärztebl 43:B2447

    Google Scholar 

  6. Bakker J, Coffernils M, Leon M, Gris P, Vincent JL (1991) Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest 99:956–962

    Article  PubMed  CAS  Google Scholar 

  7. Bergqvist D (1990) Dextran zur Thromboseprophylaxe. In: Messmer K, Peter K (Hrsg) Infusionstherapie mit Dextranen. Neue Aspekte und Stellenwert. Zuckschwerdt, München, S 28–36

    Google Scholar 

  8. Brückner UB, Messmer K (1991) Organdurchblutung und Sauerstoffversorgung bei limitierter isovolämischer Hämodilution mit 6% HAES 200/0,62 und 6% Dextran 70. Anästhesist 40: 434–440

    Google Scholar 

  9. Bundesärztekammer (1995) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  10. Cain SM (1991) Physiological and pathological oxygen supply dependency. In: Gutierrez G, Vincent JL (eds) Tissue oxygen utilization. Update in intensive care and emergency medicine, vol 12. Springer, Berlin Heidelberg New York Tokio, pp 114–123

    Chapter  Google Scholar 

  11. Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers. BMJ 317:235–240

    Article  Google Scholar 

  12. Czer LSC, Shoemaker WC (1978) Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 147:363–368

    PubMed  CAS  Google Scholar 

  13. Dieterich HJ (2001) Kolloide in der Intensivmedizin. Anästhesist 50: 54–68

    Article  CAS  Google Scholar 

  14. Engelhardt W (1995) Gibt es gesicherte Indikationen für Humanalbumin in der Anästhesiologie und Intensivmedizin? Anaesth Intensivmed 36:120–127

    Google Scholar 

  15. Fiddian-Green RG (1995) Gastric intramucosal pH, tissue oxygenation and acid-base balance. Br J Anaesth 74:591–606

    Article  PubMed  CAS  Google Scholar 

  16. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists (1994) Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. JAMA 271:777–781

    Article  Google Scholar 

  17. Guyton AC (1991) Circulatory shock and physiology of its treatment. In: Guyton AC (ed) Textbook of medical physiology. Saunders, Philadelphia, pp 263–271

    Google Scholar 

  18. Hedlund JU, Hansson LO, Örtqvist AB (1995) Hypoalbminemia in hospitalized patients with community-acquired pneumonia. Arch Intern Med 155:1438–1442

    Article  PubMed  CAS  Google Scholar 

  19. Hébert PC, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417

    Article  PubMed  Google Scholar 

  20. Kapiotis S, Quehenberger P, Eichler HG et al. (1994) Effect of hydroxy-ethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Crit Care Med 22:606–612

    Article  PubMed  CAS  Google Scholar 

  21. Kreimeier U, Christ F, Kraft D et al. (1995) Anaphylaxis due to hydroxy-ethyl-starch-reactive antibodies. Lancet 346:49–50

    Article  PubMed  CAS  Google Scholar 

  22. Kreimeier U, Messmer K (1996) Hemodilution in clinical surgery:state of the art 1996. World J Surg 20:1208–1217

    Article  PubMed  CAS  Google Scholar 

  23. Kreimeier U, Peter K (1993) Schock. In: Lawin P, van Aken H, Brüssel T, Prien T (Hrsg) Praxis der Intensivbehandlung. Thieme, Stuttgart, S 658–701

    Google Scholar 

  24. Kruse JA (1987) Blood lactate and oxygen transport. Intens Care World 4:121–125

    Google Scholar 

  25. Laubenthal H (1997) BSE und Heparin- bzw. Gelatinepräparate. Anästhesist 46:253–254

    CAS  Google Scholar 

  26. Laxenaire MC, Charpentier C, Feldman L, Groupe Français d’Etude de la Tolérance des Substituts Plasmatiques (1994) Anaphylactoid reactions to colloid plasma substitutes: frequency, risk factors, mechanisms. A French prospective multicentre inquiry. Ann Fr Anesth Réanim 13:301–310

    Article  PubMed  CAS  Google Scholar 

  27. Leslie SD, Toy PTCY (1991) Laboratory hemostatic abnormalities in massively transfused patients given red blood cells and crystalloid. Am J Clin Pathol 96:770–773

    PubMed  CAS  Google Scholar 

  28. Ljungström KG (1993) Safety of dextran in relation to other colloids — ten years experience with hapten inhibition. Infusionsther Transfusionsmed 20:206–210

    PubMed  Google Scholar 

  29. Lorenz W, Duda D, Dick W et al., (1994) Incidence and clinical importance of perioperative histamine-release: randomized study of volume loading and antihistamines after induction of anesthesia. Lancet 343:933–940

    Article  PubMed  CAS  Google Scholar 

  30. Mardel SN, Saunders F, Ollerenshaw L, Edwards C, Baddeley D (1996) Reduced quality of in-vitro clot formation with gelatin-based plasma substitutes (letter to the editor). Lancet 347:825

    Article  PubMed  CAS  Google Scholar 

  31. Menger MD, Thierjung C, Hammersen F, Messmer K (1993) Dextran vs. hydroxyethylstarch in inhibition of postischemic leukocyte adherence in striated muscle. Circ Shock 41:248–255

    PubMed  CAS  Google Scholar 

  32. Messmer K, Frey L (1991) Das Prinzip der Hämodilution. Chirurg 62: 769–774

    PubMed  CAS  Google Scholar 

  33. Messmer K (1967) Intestinale Faktoren im Schock: Intestinaler Kreislauf. Langenb Arch Chir 319:890–909

    Article  CAS  Google Scholar 

  34. Messmer K, Frey L (1991) Das Prinzip der Hämodilution. Chirurg 62: 769–774

    PubMed  CAS  Google Scholar 

  35. Modig J (1986) Effectiveness of Dextran 70 vs. Ringer’s acetate in traumatic shock and adult respiratory distress syndrome. Crit Care Med 14:454–457

    Article  PubMed  CAS  Google Scholar 

  36. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79:1635–1641

    Article  PubMed  CAS  Google Scholar 

  37. Nelson DP, Samsel RW, Wood LDH, Schumacker PT (1988) Pathological supply dependence of systemic and intestinal O2 uptake during endotoxemia. J Appl Physiol 64:2410–2419

    PubMed  CAS  Google Scholar 

  38. Pargger H (1999) Gastric intramucosal acidosis, pHi and the tonometer: What is the benefit for patients? In:Vincent JL (Hrsg) Yearbook of intensive care and emergency medicine 1999. Springer, Berlin Heidelberg New York Tokio, pp 547–556

    Google Scholar 

  39. Randle NW, Hubert-Hartmann K, Mulheran LC (1984) Serum albumin levels: relationship to length of hospital stay. Hosp Pharm 19:802–805

    PubMed  CAS  Google Scholar 

  40. Ring J (1991) Anaphylactoid reactions to intravenous solutions used for volume substitution. Clin Rev Allergy 9:397–414

    PubMed  CAS  Google Scholar 

  41. Ring J, Messmer K (1977) Infusiontherapie mit kolloidalen Volumenersatzmitteln. Anästhesist 26:279–287

    CAS  Google Scholar 

  42. Royal College of Physicians of Edinburgh (1994) Consensus statement on red cell transfusion. Br J Anaesth 73:857–859

    Article  Google Scholar 

  43. Schramm W (2000) Blood safety in the European Community: An initiative for optimal use. Conference Proceedings from the Commission of the European Communities, Wildbad Kreuth, 20–22 May 1999. European Commission, München

    Google Scholar 

  44. Silberstein LE, Kruskall MS, Stehling LC et al. (1989) Strategies for the review of transfusion practices. JAMA 262:1993–1997

    Article  PubMed  CAS  Google Scholar 

  45. Spahn DR, Casutt M (2000) Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 93:242–255

    Article  PubMed  CAS  Google Scholar 

  46. Spahn DR, Schanz U, Pasch T (1998) Perioperative Transfusionskriterien. Anästhesist 47:1011–1020

    Article  CAS  Google Scholar 

  47. Spahn DR, Schmid ER, Seifert B, Pasch T (1996) Hemodilution tolerance in patients with coronary artery disease who are receiving chronic β-adrenergic blocker therapy. Anesth Analg 82:687–694

    PubMed  CAS  Google Scholar 

  48. Tabuchi N, de Haan J, Huet RCGG, Boonstra PW, van Oeveren W (1995) Gelatin use impairs platelet adhesion during cardiac surgery.Thromb Haemost 74:1447–1451

    PubMed  CAS  Google Scholar 

  49. Treib J, Haass A, Pindur G et al. (1997) Avoiding an impairment of Factor VIII: C by using hydroxyethyl starch with a low in vivo molecular weight. Anesth Analg 84:1391

    PubMed  CAS  Google Scholar 

  50. Tuchschmidt J, Fried J, Swinney R, Sharma OP (1989) Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 17:719–723

    Article  PubMed  CAS  Google Scholar 

  51. Van der Weyden MB, Trinker FR, Hemming M et al. (1992) Human albumin solutions: consensus statements for use in selected clinical situations. Med J Aust 157:340–343

    Google Scholar 

  52. Vincent JL (1996) End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or…? Intensive Care Med 22:3–5

    Article  PubMed  CAS  Google Scholar 

  53. Warnold I, Lundholm K (1984) Clinical significance of preoperative nutritional status in 215 noncancer patients. Ann Surg 199:299–305

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kreimeier, U., Rehm, M. (2003). Intensivtherapie im hypovolämisch-hämorrhag Schock. In: Stein, J., Jauch, KW. (eds) Praxishandbuch klinische Ernährung und Infusionstherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55896-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55896-2_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62625-8

  • Online ISBN: 978-3-642-55896-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics